United States Biotechnology & Medical Research

Invitae Corp (NVTA)

Track

Stock chart
Ticker: NVTA Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
WERNER ROBERT F.
Officer
1 sale — total 64,838 USD
Proposed sale 3 Jul 2023
Value US$3,902,401.86 | Price 334.23 | Shares 46,957
Sale 13 Jun 2023
Value US$2,401,980.69 | Price 289.39 | Shares 39,021
Sale 13 Jun 2023
Value US$9,757.42 | Price 1.38 | Shares 7,086
Sale 16 May 2023
Value US$86,599.84 | Price 1.99 | Shares 43,452
Planned sale 16 May 2023
Value US$25,855.71 | Price 1.20 | Shares 21,559
Sale 16 May 2023
Value US$54,486.60 | Price 1.20 | Shares 45,432
Sale 16 May 2023
Value US$31,752.67 | Price 1.20 | Shares 26,476
Sale 16 May 2023
Value US$31,752.67 | Price 1.20 | Shares 26,476
Sale 13 Mar 2023
Value US$3,701.25 | Price 1.41 | Shares 2,625
Sale 13 Mar 2023
Value US$3,701.25 | Price 1.41 | Shares 2,625
Sale 13 Mar 2023
Value US$2,612.73 | Price 1.41 | Shares 1,853
Sale 13 Mar 2023
Value US$3,701.25 | Price 1.41 | Shares 2,625
Sale 19 Dec 2022
Value US$23,210.11 | Price 2.08 | Shares 11,163
Sale 16 Dec 2022
Value US$91,420.16 | Price 2.04 | Shares 44,816
Planned sale 25 Aug 2022
Value US$4,657.50 | Price 3.45 | Shares 1,350
Sale 16 Aug 2022
Value US$100,493.38 | Price 4.55 | Shares 22,085
Sale 16 Aug 2022
Value US$14,797.58 | Price 4.55 | Shares 3,252
Sale 16 Aug 2022
Value US$32,070.51 | Price 4.55 | Shares 7,048
Sale 16 Aug 2022
Value US$32,070.51 | Price 4.55 | Shares 7,048
Planned sale 19 May 2022
Value US$9,336.40 | Price 3.40 | Shares 2,746
Sale 17 May 2022
Value US$23,233.99 | Price 3.81 | Shares 6,098
Sale 17 May 2022
Value US$69,709.59 | Price 3.81 | Shares 18,296
Planned sale 17 May 2022
Value US$23,233.99 | Price 3.81 | Shares 6,098
Sale 17 May 2022
Value US$107,806.78 | Price 3.81 | Shares 28,295
Sale 17 May 2022
Value US$64,931.72 | Price 3.81 | Shares 17,042
Planned sale 17 May 2022
Value US$28,027.10 | Price 3.81 | Shares 7,356
Sale 14 Mar 2022
Value US$15,766.53 | Price 6.69 | Shares 2,358
Sale 14 Mar 2022
Value US$21,991.90 | Price 6.69 | Shares 3,289
Planned sale 14 Mar 2022
Value US$120,286.26 | Price 6.69 | Shares 17,987
Sale 14 Mar 2022
Value US$130,992.79 | Price 6.69 | Shares 19,588
Sale 14 Mar 2022
Value US$209,885.69 | Price 6.69 | Shares 31,389
Planned sale 11 Nov 2021
Value US$649,567.94 | Price 21.89 | Shares 29,675
Planned sale 22 Oct 2021
Value US$103,120.50 | Price 28.06 | Shares 3,675
Sale 22 Jul 2021
Value US$108,008.25 | Price 29.39 | Shares 3,675
Sale 15 Jun 2021
Value US$450,686.66 | Price 30.30 | Shares 14,874
Sale 14 Jun 2021
Value US$313,404.74 | Price 31.63 | Shares 9,910
Planned sale 14 Jun 2021
Value US$313,404.74 | Price 31.63 | Shares 9,910
Sale 14 Jun 2021
Value US$313,404.74 | Price 31.63 | Shares 9,910
Sale 14 Jun 2021
Value US$279,376.13 | Price 31.63 | Shares 8,834
Planned sale 14 Jun 2021
Value US$363,303.10 | Price 31.58 | Shares 11,506
Sale 20 May 2021
Value US$102,900.00 | Price 28.00 | Shares 3,675
Sale 18 May 2021
Value US$0.00 | Price 0.00 | Shares 3,576
Sale 18 May 2021
Value US$0.00 | Price 0.00 | Shares 1,000
Sale 18 May 2021
Value US$0.00 | Price 0.00 | Shares 1,469
Sale 18 May 2021
Value US$0.00 | Price 0.00 | Shares 262
Sale 18 May 2021
Value US$0.00 | Price 0.00 | Shares 346
Planned sale 14 Apr 2021
Value US$4,102.00 | Price 41.02 | Shares 100
Planned sale 14 Apr 2021
Value US$395,580.73 | Price 40.37 | Shares 9,799
Planned sale 14 Apr 2021
Value US$393,526.74 | Price 39.38 | Shares 9,994
Planned sale 22 Mar 2021
Value US$26,148.43 | Price 43.51 | Shares 601
Planned sale 22 Mar 2021
Value US$78,276.08 | Price 42.89 | Shares 1,825
Planned sale 22 Mar 2021
Value US$52,171.85 | Price 41.77 | Shares 1,249
Sale 15 Mar 2021
Value US$575,940.56 | Price 42.90 | Shares 13,425
Sale 15 Mar 2021
Value US$600,265.20 | Price 42.90 | Shares 13,992
Sale 15 Mar 2021
Value US$268,772.26 | Price 42.90 | Shares 6,265
Sale 15 Mar 2021
Value US$509,744.93 | Price 42.90 | Shares 11,882
Sale 15 Mar 2021
Value US$533,812.17 | Price 42.90 | Shares 12,443
Sale 12 Mar 2021
Value US$268,772.26 | Price 42.90 | Shares 6,265
Sale 12 Mar 2021
Value US$510,259.74 | Price 42.90 | Shares 11,894
Sale 12 Mar 2021
Value US$268,772.26 | Price 42.90 | Shares 6,265
Sale 12 Mar 2021
Value US$419,825.27 | Price 42.90 | Shares 9,786
Planned sale 4 Mar 2021
Value US$3,916.00 | Price 39.16 | Shares 100
Planned sale 4 Mar 2021
Value US$11,427.00 | Price 38.09 | Shares 300
Planned sale 4 Mar 2021
Value US$44,684.04 | Price 37.24 | Shares 1,200
Planned sale 4 Mar 2021
Value US$74,724.07 | Price 36.01 | Shares 2,075
Planned sale 2 Mar 2021
Value US$13,250.01 | Price 44.17 | Shares 300
Planned sale 2 Mar 2021
Value US$47,672.02 | Price 43.34 | Shares 1,100
Planned sale 2 Mar 2021
Value US$68,003.20 | Price 42.50 | Shares 1,600
Planned sale 1 Mar 2021
Value US$145,893.61 | Price 43.96 | Shares 3,319
Planned sale 1 Mar 2021
Value US$64,195.87 | Price 43.35 | Shares 1,481
Planned sale 1 Mar 2021
Value US$8,300.00 | Price 41.50 | Shares 200
Planned sale 25 Feb 2021
Value US$12,524.01 | Price 41.75 | Shares 300
Planned sale 25 Feb 2021
Value US$53,259.96 | Price 40.97 | Shares 1,300
Planned sale 25 Feb 2021
Value US$91,195.92 | Price 39.65 | Shares 2,300
Planned sale 25 Feb 2021
Value US$42,844.01 | Price 38.95 | Shares 1,100
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-07-03 2023-07-03 PrS Proposed sale
2.4
WERNER ROBERT F.

Officer

Officer
46,957
334.23
US$3,902,402 		46,957 334.23 US$3,902,402
2023-06-15 2023-06-13 S Sale
Brida Thomas

See Remarks

Officer
39,021 -15.7%
289.39
US$2,401,981 		39,021 -15.7% 289.39 US$2,401,981
2023-06-15 2023-06-13 S Sale
Nussbaum Robert L

Chief Medical Officer

Officer
2,593 -10.6%
414.21
US$253,439 		2,593 -10.6% 414.21 US$253,439
2023-05-18 2023-05-16 S Sale
Wen Yafei

Chief Financial Officer

Officer
43,452 -5.8%
1.99
US$86,600 		43,452 -5.8% 1.99 US$86,600
2023-05-18 2023-05-16 PlS Planned sale
2.4
WERNER ROBERT F.

Chief Accounting Officer

Officer
21,559 -5.7%
1.20
US$25,856 		21,559 -5.7% 1.20 US$25,856
2023-05-18 2023-05-16 S Sale
Knight Kenneth D.

Chief Executive Officer

Executive Director
45,432 -2.6%
1.20
US$54,487 		45,432 -2.6% 1.20 US$54,487
2023-05-18 2023-05-16 S Sale
Nussbaum Robert L

Chief Medical Officer

Officer
26,476 -4.4%
1.20
US$31,753 		26,476 -4.4% 1.20 US$31,753
2023-05-18 2023-05-16 S Sale
Brida Thomas

See Remarks

Officer
26,476 -3.6%
1.20
US$31,753 		26,476 -3.6% 1.20 US$31,753
2023-03-15 2023-03-13 S Sale
Brida Thomas

See Remarks

Officer
2,625 -0.6%
1.41
US$3,701 		2,625 -0.6% 1.41 US$3,701
2023-03-15 2023-03-13 S Sale
Nussbaum Robert L

Chief Medical Officer

Officer
2,625 -0.6%
1.41
US$3,701 		2,625 -0.6% 1.41 US$3,701
2023-03-15 2023-03-13 S Sale
Knight Kenneth D.

Chief Executive Officer

Executive Director
1,853 -0.4%
1.41
US$2,613 		1,853 -0.4% 1.41 US$2,613
2023-03-15 2023-03-13 S Sale
Wen Yafei

Chief Financial Officer

Officer
2,625 -0.6%
1.41
US$3,701 		2,625 -0.6% 1.41 US$3,701
2022-12-20 2022-12-19 S Sale
3.7
George Sean E
Non-Executive Director
11,163 -1.5%
2.08
US$23,210 		11,163 -1.5% 2.08 US$23,210
2022-12-20 2022-12-16 S Sale
3.7
George Sean E
Non-Executive Director
44,816 -5.7%
2.04
US$91,420 		44,816 -5.7% 2.04 US$91,420
2022-08-29 2022-08-25 PlS Planned sale
2.4
WERNER ROBERT F.

Chief Accounting Officer

Officer
1,350 -0.5%
3.45
US$4,658 		1,350 -0.5% 3.45 US$4,658
2022-08-18 2022-08-16 S Sale
3.7
George Sean E
Non-Executive Director
22,085 -2.7%
4.55
US$100,493 		22,085 -2.7% 4.55 US$100,493
2022-08-18 2022-08-16 S Sale
2.4
WERNER ROBERT F.

Chief Accounting Officer

Officer
3,252 -1.6%
4.55
US$14,798 		3,252 -1.6% 4.55 US$14,798
2022-08-18 2022-08-16 S Sale
Brida Thomas

See remarks

Officer
7,048 -1.8%
4.55
US$32,071 		7,048 -1.8% 4.55 US$32,071
2022-08-18 2022-08-16 S Sale
Nussbaum Robert L

Chief Medical Officer

Officer
7,048 -1.7%
4.55
US$32,071 		7,048 -1.7% 4.55 US$32,071
2022-05-19 2022-05-19 PlS Planned sale
2.4
WERNER ROBERT F.

Chief Accounting Officer

Officer
2,746 -1.3%
3.40
US$9,336 		2,746 -1.3% 3.40 US$9,336
2022-05-19 2022-05-17 S Sale
Nussbaum Robert L

Chief Medical Officer

Officer
6,098 -1.5%
3.81
US$23,234 		6,098 -1.5% 3.81 US$23,234
2022-05-19 2022-05-17 S Sale
3.7
George Sean E

President & CEO

Executive Director
18,296 -2.3%
3.81
US$69,710 		18,296 -2.3% 3.81 US$69,710
2022-05-19 2022-05-17 PlS Planned sale
Brida Thomas

See Remarks

Officer
6,098 -1.5%
3.81
US$23,234 		6,098 -1.5% 3.81 US$23,234
2022-05-19 2022-05-17 S Sale
Knight Kenneth D.

Chief Operating Officer

Officer
28,295 -5.2%
3.81
US$107,807 		28,295 -5.2% 3.81 US$107,807
2022-05-19 2022-05-17 S Sale
Wen Yafei

Chief Financial Officer

Officer
17,042 -4.7%
3.81
US$64,932 		17,042 -4.7% 3.81 US$64,932
2022-05-19 2022-05-17 PlS Planned sale
2.4
WERNER ROBERT F.

Chief Accounting Officer

Officer
7,356 -3.5%
3.81
US$28,027 		7,356 -3.5% 3.81 US$28,027
2022-03-21 2022-03-14 S Sale
Knight Kenneth D.

Chief Operating Officer

Officer
2,358 -0.7%
6.69
US$15,767 		2,358 -0.7% 6.69 US$15,767
2022-03-16 2022-03-14 S Sale
Wen Yafei

Chief Financial Officer

Officer
3,289 -2.4%
6.69
US$21,992 		3,289 -2.4% 6.69 US$21,992
2022-03-16 2022-03-14 PlS Planned sale
Brida Thomas

General Counsel

Officer
17,987 -7.3%
6.69
US$120,286 		17,987 -7.3% 6.69 US$120,286
2022-03-16 2022-03-14 S Sale
Nussbaum Robert L

Chief Medical Officer

Officer
19,588 -7.5%
6.69
US$130,993 		19,588 -7.5% 6.69 US$130,993
2022-03-16 2022-03-14 S Sale
3.7
George Sean E

President & CEO

Executive Director
31,389 -3.7%
6.69
US$209,886 		31,389 -3.7% 6.69 US$209,886
2021-11-15 2021-11-11 PlS Planned sale
Nussbaum Robert L

Chief Medical Officer

Officer
29,675 -10.8%
21.89
US$649,568 		29,675 -10.8% 21.89 US$649,568
2021-10-26 2021-10-22 PlS Planned sale
3.7
George Sean E

President & CEO

Executive Director
3,675 -0.5%
28.06
US$103,120 		3,675 -0.5% 28.06 US$103,120
2021-07-23 2021-07-22 S Sale
3.7
George Sean E

President & CEO

Executive Director
3,675 -0.5%
29.39
US$108,008 		3,675 -0.5% 29.39 US$108,008
2021-06-17 2021-06-15 S Sale
Knight Kenneth D.

Chief Operating Officer

Officer
14,874 -4.6%
30.30
US$450,687 		14,874 -4.6% 30.30 US$450,687
2021-06-16 2021-06-14 S Sale
Nussbaum Robert L

Chief Medical Officer

Officer
9,910 -3.6%
31.63
US$313,405 		9,910 -3.6% 31.63 US$313,405
2021-06-16 2021-06-14 PlS Planned sale
Brida Thomas

General Counsel

Officer
9,910 -3.9%
31.63
US$313,405 		9,910 -3.9% 31.63 US$313,405
2021-06-16 2021-06-14 S Sale
Guyer Shelly D

Chief Financial Officer

Officer
9,910 -3.9%
31.63
US$313,405 		9,910 -3.9% 31.63 US$313,405
2021-06-16 2021-06-14 S Sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
8,834 -4.0%
31.63
US$279,376 		8,834 -4.0% 31.63 US$279,376
2021-06-16 2021-06-14 PlS Planned sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
11,506 -4.9%
31.58
US$363,303 		11,506 -4.9% 31.58 US$363,303
2021-05-24 2021-05-20 S Sale
3.7
George Sean E

President & CEO

Executive Director
3,675 -0.5%
28.00
US$102,900 		3,675 -0.5% 28.00 US$102,900
2021-05-20 2021-05-18 S Sale
2.4
WERNER ROBERT F.

Chief Accounting Officer

Officer
3,576
0.00
US$0 		3,576 0.00 US$0
2021-05-20 2021-05-18 S Sale
2.4
WERNER ROBERT F.

Chief Accounting Officer

Officer
1,000
0.00
US$0 		1,000 0.00 US$0
2021-05-20 2021-05-18 S Sale
2.4
WERNER ROBERT F.

Chief Accounting Officer

Officer
1,469
0.00
US$0 		1,469 0.00 US$0
2021-05-20 2021-05-18 S Sale
2.4
WERNER ROBERT F.

Chief Accounting Officer

Officer
262
0.00
US$0 		262 0.00 US$0
2021-05-20 2021-05-18 S Sale
2.4
WERNER ROBERT F.

Chief Accounting Officer

Officer
346
0.00
US$0 		346 0.00 US$0
2021-04-15 2021-04-14 PlS Planned sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
100 -0.1%
41.02
US$4,102 		100 -0.1% 41.02 US$4,102
2021-04-15 2021-04-14 PlS Planned sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
9,799 -4.9%
40.37
US$395,581 		9,799 -4.9% 40.37 US$395,581
2021-04-15 2021-04-14 PlS Planned sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
9,994 -4.8%
39.38
US$393,527 		9,994 -4.8% 39.38 US$393,527
2021-03-23 2021-03-22 PlS Planned sale
3.7
George Sean E

President & CEO

Executive Director
601 -0.1%
43.51
US$26,148 		601 -0.1% 43.51 US$26,148
2021-03-23 2021-03-22 PlS Planned sale
3.7
George Sean E

President & CEO

Executive Director
1,825 -0.3%
42.89
US$78,276 		1,825 -0.3% 42.89 US$78,276
2021-03-23 2021-03-22 PlS Planned sale
3.7
George Sean E

President & CEO

Executive Director
1,249 -0.2%
41.77
US$52,172 		1,249 -0.2% 41.77 US$52,172
2021-03-17 2021-03-15 S Sale
3.7
George Sean E

President & CEO

Executive Director
13,425 -1.9%
42.90
US$575,941 		13,425 -1.9% 42.90 US$575,941
2021-03-17 2021-03-15 S Sale
3.7
George Sean E

President & CEO

Executive Director
13,992 -2.0%
42.90
US$600,265 		13,992 -2.0% 42.90 US$600,265
2021-03-17 2021-03-15 S Sale
Guyer Shelly D

Chief Financial Officer

Officer
6,265 -2.7%
42.90
US$268,772 		6,265 -2.7% 42.90 US$268,772
2021-03-17 2021-03-15 S Sale
Guyer Shelly D

Chief Financial Officer

Officer
11,882 -4.8%
42.90
US$509,745 		11,882 -4.8% 42.90 US$509,745
2021-03-17 2021-03-15 S Sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
12,443 -5.5%
42.90
US$533,812 		12,443 -5.5% 42.90 US$533,812
2021-03-17 2021-03-12 S Sale
Nussbaum Robert L

Chief Medical Officer

Officer
6,265 -2.6%
42.90
US$268,772 		6,265 -2.6% 42.90 US$268,772
2021-03-17 2021-03-12 S Sale
Nussbaum Robert L

Chief Medical Officer

Officer
11,894 -4.8%
42.90
US$510,260 		11,894 -4.8% 42.90 US$510,260
2021-03-17 2021-03-12 S Sale
Brida Thomas

General Counsel

Officer
6,265 -2.9%
42.90
US$268,772 		6,265 -2.9% 42.90 US$268,772
2021-03-17 2021-03-12 S Sale
Brida Thomas

General Counsel

Officer
9,786 -4.3%
42.90
US$419,825 		9,786 -4.3% 42.90 US$419,825
2021-03-05 2021-03-04 PlS Planned sale
3.7
George Sean E

President & CEO

Executive Director
100 -0.0%
39.16
US$3,916 		100 -0.0% 39.16 US$3,916
2021-03-05 2021-03-04 PlS Planned sale
3.7
George Sean E

President & CEO

Executive Director
300 -0.0%
38.09
US$11,427 		300 -0.0% 38.09 US$11,427
2021-03-05 2021-03-04 PlS Planned sale
3.7
George Sean E

President & CEO

Executive Director
1,200 -0.2%
37.24
US$44,684 		1,200 -0.2% 37.24 US$44,684
2021-03-05 2021-03-04 PlS Planned sale
3.7
George Sean E

President & CEO

Executive Director
2,075 -0.3%
36.01
US$74,724 		2,075 -0.3% 36.01 US$74,724
2021-03-03 2021-03-02 PlS Planned sale
Guyer Shelly D

Chief Financial Officer

Officer
300 -0.1%
44.17
US$13,250 		300 -0.1% 44.17 US$13,250
2021-03-03 2021-03-02 PlS Planned sale
Guyer Shelly D

Chief Financial Officer

Officer
1,100 -0.5%
43.34
US$47,672 		1,100 -0.5% 43.34 US$47,672
2021-03-03 2021-03-02 PlS Planned sale
Guyer Shelly D

Chief Financial Officer

Officer
1,600 -0.7%
42.50
US$68,003 		1,600 -0.7% 42.50 US$68,003
2021-03-03 2021-03-01 PlS Planned sale
Brida Thomas

General Counsel

Officer
3,319 -1.6%
43.96
US$145,894 		3,319 -1.6% 43.96 US$145,894
2021-03-03 2021-03-01 PlS Planned sale
Brida Thomas

General Counsel

Officer
1,481 -0.7%
43.35
US$64,196 		1,481 -0.7% 43.35 US$64,196
2021-03-03 2021-03-01 PlS Planned sale
Brida Thomas

General Counsel

Officer
200 -0.1%
41.50
US$8,300 		200 -0.1% 41.50 US$8,300
2021-02-26 2021-02-25 PlS Planned sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
300 -0.1%
41.75
US$12,524 		300 -0.1% 41.75 US$12,524
2021-02-26 2021-02-25 PlS Planned sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
1,300 -0.6%
40.97
US$53,260 		1,300 -0.6% 40.97 US$53,260
2021-02-26 2021-02-25 PlS Planned sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
2,300 -1.1%
39.65
US$91,196 		2,300 -1.1% 39.65 US$91,196
2021-02-26 2021-02-25 PlS Planned sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
1,100 -0.5%
38.95
US$42,844 		1,100 -0.5% 38.95 US$42,844
Explore more

More insider trading research around Invitae Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America